Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Donald Ingber
Harvard University, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Emulate, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
See attached.
Lung-on-a-chip pulmonary fibrosis model for drug discovery
PROJECT NARRATIVE Pulmonary fibrosis is a common and devastating disorder without effective pharmacological treatment options, leading to a median survival time of only 2.5 to 3.5 years after diagnosis. To complement animal research models for screening of potential therapeutics, we propose the development of a pulmonary fibrosis model using a cell-based platform that recapitulates the human lung microenvironment. The goals of this project are to determine the mechanisms of pulmonary fibrosis through characterization of the contribution of donor fibroblasts, environmental factors, and immune and inflammatory cell mediators, then use the knowledge of mechanistic elements to aid in the discovery of new therapeutics for treating pulmonary fibrosis.
Filed on February 15, 2019.
Tell us what you know about Donald Ingber's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Donald Ingber”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Donald Ingber | Harvard Medical School | Conflict of Interest | Emulate, Inc. | Value cannot be readily determined |
| Donald Ingber | Harvard University | Conflict of Interest | Emulate, Inc. | Value cannot be readily determined |
| Donald Ingber | Harvard Medical School | Conflict of Interest | Emulate, Inc. | $40,000 - $59,999 |
| Donald Ingber | Harvard University | Conflict of Interest | Emulate, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.